No Detail Found!

Synthesis and Biological Evaluation of Novel 4-Phenylaminobenzofuro[2,3-d]pyrimidine Derivatives

Author(s)
Ju liu College of Pharmacy of Liaoning University, API Engineering Technology Research Center of Liaoning Province, Key Laboratory of New Drug Research and Development of Liaoning Province,66 Chongshan Road, Huanggu District, Shenyang 110036, Liaoning,P. R. China
Jun Li College of Pharmacy of Liaoning University, API Engineering Technology Research Center of Liaoning Province, Key Laboratory of New Drug Research and Development of Liaoning Province,66 Chongshan Road, Huanggu District, Shenyang 110036, Liaoning,P. R. China
Jian-tao Shi College of Pharmacy of Liaoning University, API Engineering Technology Research Center of Liaoning Province, Key Laboratory of New Drug Research and Development of Liaoning Province,66 Chongshan Road, Huanggu District, Shenyang 110036, Liaoning,P. R. China
Jie Li College of Pharmacy of Liaoning University, API Engineering Technology Research Center of Liaoning Province, Key Laboratory of New Drug Research and Development of Liaoning Province,66 Chongshan Road, Huanggu District, Shenyang 110036, Liaoning,P. R. China
Xue-chen Hao College of Pharmacy of Liaoning University, API Engineering Technology Research Center of Liaoning Province, Key Laboratory of New Drug Research and Development of Liaoning Province,66 Chongshan Road, Huanggu District, Shenyang 110036, Liaoning,P. R. China
Duang-zheng Song College of Pharmacy of Liaoning University, API Engineering Technology Research Center of Liaoning Province, Key Laboratory of New Drug Research and Development of Liaoning Province,66 Chongshan Road, Huanggu District, Shenyang 110036, Liaoning,P. R. China
Yang Wang College of Pharmacy of Liaoning University, API Engineering Technology Research Center of Liaoning Province, Key Laboratory of New Drug Research and Development of Liaoning Province,66 Chongshan Road, Huanggu District, Shenyang 110036, Liaoning,P. R. China
Shi Ding College of Pharmacy of Liaoning University, API Engineering Technology Research Center of Liaoning Province, Key Laboratory of New Drug Research and Development of Liaoning Province,66 Chongshan Road, Huanggu District, Shenyang 110036, Liaoning,P. R. China
Ye Chen College of Pharmacy of Liaoning University, API Engineering Technology Research Center of Liaoning Province, Key Laboratory of New Drug Research and Development of Liaoning Province,66 Chongshan Road, Huanggu District, Shenyang 110036, Liaoning,P. R. China
Abstract
Summary: A series of novel 4-phenylaminobenzofuro[2,3-d]pyrimidine derivatives had been prepared and assessed for their in vitro antiproliferative activities against three lung cancer cell lines (A549, H460 and H1975). The bioassay results showed most of the designed compounds exhibited potential antiproliferation activities. Among them, compound 8f exhibited remarkable inhibitory activity against A549 and H460 cell lines with IC50 value of 2.54 µM and 2.68 µM, respectively, which was comparable to that of the positive control sorafenib (IC50 = 2.69 µM for A549 and 3.71 µM for H460). AO/EB staining suggests that compound 8f could induce apoptosis in A549 cells. Furthermore, cell cycle analyses show that compound 8f increased G0/G1 A549 cells arrest in a concentration-dependent manner. The preliminary structure-activity relationships (SARs) studies indicated that mono-electron-withdrawing groups (mono-EWGs) on the phenyl ring are positive on the antitumor activity.
Publication Details
Page(s) 564-571
Published Journal: Journal of Chemical Society of Pakistan, Volume: 42, Issue: 4, Year: 2020

Request the full text from PASTIC

Keywords
antitumor activity, 4-phenylaminobenzofuro[2, 3-d]pyrimidine, synthesis, Structure-activity
References
Transl. Lung Cancer Res. .2015 .. , 4(327) : .
Siegel R.,Ma J.,Zou Z.,Jemal A.,Clin A. .2014 .. , 64(9) : .
Min Z.,Am Surg. Oncol. Clin. N. .2016 .Classification and pathology of lung cancer,. , 25(447) : .
W. D. Travis M. B.,Beasley M. B. .2015 .The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. , 10(1243) : .
Am. Coll. Cardiol. .2015 .. , 66(1160) : .
Liu R.,Xu K. P.,Tan G. S. .2015 .Cyclooxygenase-2 inhibitors in lung cancer treatment: bench to bed, Eur. , 769(127) : .
P. Wu T. E.,Nielsen M. H.,Clausen M. H. .2015 .FDA-approved small-molecule kinase inhibitors. Trends Pharmacol Sci., 36(422) : .
Abd E. H. S. R.,Lasheen D. S.,Hassan M. A.,Abouzid K. A. M. .2016 .pyrimidine-based compounds as dual EGFR/HER-2 inhibitors, Arch. Design and synthesis of 4-anilinothieno[2, 349(827) : 3.
Ding H. G.,Cai Z. Q.,Hou L.,Hu Z. Q.,Jin Z. S.,Xu D.,Cao H.,M. M. Meng Y. H.,Xie D. Q.,Zheng D. Q. .2019 .Synthesis and evaluation of some novel 6-substituted quinazoline derivatives as antitumor agents. J. Chem. Soc. Pak., 41(186) : .
Hutson T. E.,Sternberg C. N. .2008 .Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma, Expert. , 17(253) : .
Friboulet N.,Li R.,Katayama C. C.,Lee J. F.,Gainorand A. S.,Crystal A. S. .2014 .The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell Lung cancer, Can. , 4(662) : .
Kim D. W.,Tiseo M.,Ahn M. J.,Reckamp K. L.,Hansenand K. H.,Kim S. W. .2017 .Brigatinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-Small-cell lung cancer: a randomized, multicenter phase II trial. , 35(2490) : .
M. Maemondo A.,Inoue K.,Kobayashi S.,Sugawara S.,Oizumi H.,Isobe H.,Med N. Engl. J. .2010 .Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. , 362(2380) : .
M. D. Marquez S.,Popat S. .2015 .Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer, Future Oncol. , 11(2525) : .
J. C. Chuang A. A.,Salahudeen H. A.,Wakelee H. A. .2016 .Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions, Expert. , 17(989) : .
J. F. Sheng Z. H.,Liu M.,Yan X. J.,Zhang D. J.,Wang J.,Xu E. S.,Zhang E. S. .2017 .Biomass-involved synthesis of n-substituted benzofuro[2,3-d]pyrimidine-4-amines and biological evaluation as novel EGFR tyrosine kinase inhibitors. Org. Biomol. Chem, 15(4971) : .
J. T. Shi Y. L.,Gong J.,Li Y.,Wang Y.,Chen S.,Ding S.,- S. .2019 .Structure and Biological Activity of 2-[2-(4-fluorobenzylidene)hydrazinyl]-4-(1-met hyl. Chinese J. Struct. Chem, 38(9) : 2.
Liu R.,Wu X.,Dual AO .2015 .EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry, Med. Basic. Res., 21(15) : .
0

Citations

0

Downloads

20

Views